Inhibition Of Olfactory Neurosensory Function To Treat Eating Disorders And Obesity


The use of calcium channel blockers administered intra-nasally to inhibit olfactory sensory perception to treat eating disorders, including obesity, is described. Also described is a method of reducing food intake in a subject by administering a pharmaceutical composition comprising an effective amount of a calcium channel blocker to the nasal mucosa, as well as screening methods for drugs to be used in treating obesity or associated disorders.

Download PDF
Document Preview
Document History
  • Publication: Nov 21, 2006
  • Application: Feb 18, 2003
    US US 36918803 A
  • Priority: Feb 18, 2003
    US US 36918803 A

Sign in to the Lens

Release 5.10.0: Improved patent search performance, saved query alerts, increased user privacy and more!

Improved Search Performance

Upgraded patent search index servers to improve search performance.

Saved Query Alerts.

Improvements to in saved query alerts emails and better formatting of links.

Increased User Privacy.

Removed Google Maps dependency in a Patents Family page.